| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2020 | NEO Neogenomics Inc | Pedulla Denise E | General Counsel | Sell | 2,262 | $42.00 | $95,004.00 | -3.8% | |
| Nov 10, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 11,402 | $49.60 | $565,581.66 | -0.1% | |
| Nov 10, 2020 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 1,430 | $1,159.69 | $1,658,359.45 | -63.2% | |
| Nov 9, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 250,000 | $3.18 | $794,669.29 | - | |
| Nov 9, 2020 | MTD Mettler Toledo International Inc/ | Keller Gerry64 | Head Of Process Analytics | Sell | 388 | $1,182.48 | $458,802.24 | -63.9% | |
| Nov 9, 2020 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 2,222 | $116.16 | $258,107.52 | -3.8% | |
| Nov 9, 2020 | WAT Waters Corp /de/ | Berendt Michael J54 | Director | Sell | 4,000 | $230.10 | $920,400.00 | -15.4% | |
| Nov 9, 2020 | XGN Exagen Inc. | Tullis James L L73 | Director, 10% Owner | Sell | 882 | $16.21 | $14,293.16 | -2.7% | |
| Nov 9, 2020 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 1,114 | $1,182.48 | $1,317,282.72 | -17.7% | |
| Nov 6, 2020 | WST West Pharmaceutical Services Inc | Miller George Lloyd | Sr. VP, GC &Corp. Sec. | Sell | 9,000 | $296.67 | $2,670,041.04 | -33.7% | |
| Nov 6, 2020 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 21,250 | $43.44 | $923,106.29 | -12.4% | |
| Nov 6, 2020 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 6,107 | $140.14 | $855,834.98 | -37.2% | |
| Nov 6, 2020 | BIO Bio-Rad Laboratories, Inc. | Tumolo Annette71 | Executive Vice President | Sell | 1,200 | $640.72 | $768,865.30 | -8.1% | |
| Nov 5, 2020 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 10,000 | $53.48 | $534,791.10 | -0.8% | |
| Nov 5, 2020 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 6,406 | $40.69 | $260,650.93 | -2.8% | |
| Nov 5, 2020 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 1,111 | $111.00 | $123,321.00 | -1.8% | |
| Nov 5, 2020 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,500 | $50.70 | $380,225.00 | -0.2% | |
| Nov 5, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 18,750 | $49.63 | $930,622.73 | -0.2% | |
| Nov 4, 2020 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 2,222 | $107.47 | $238,787.23 | -1.8% | |
| Nov 4, 2020 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 6,739 | $250.28 | $1,686,627.27 | -13.9% | |
| Nov 3, 2020 | DHR Danaher Corp /de/ | Zerhouni Elias A.50 | Director | Sell | 8,898 | $233.71 | $2,079,594.12 | -11.7% | |
| Nov 3, 2020 | CDNA Caredx, Inc. | Bell Michael Brian | Chief Financial Officer | Sell | 32,574 | $48.15 | $1,568,486.96 | -24.0% | |
| Nov 3, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 2,690 | $105.28 | $283,203.20 | -36.7% | |
| Nov 3, 2020 | CRL Charles River Laboratories International, Inc. | Barbo William D66 | Corporate Executive VP &CCO | Sell | 2,150 | $236.29 | $508,015.12 | -18.0% | |
| Nov 2, 2020 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 32,819 | $121.11 | $3,974,738.09 | -0.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.